Agios Pharmaceuticals, Inc.
AGIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001439222
In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Agios Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 221 | 2 | 216 | −3 |
| Shares | 60.1M | 50.9K | 61.7M | +1.64M (+2.7%) |
| Value | $1.76B | $1.49M | $2.05B | +$290.1M (+16.5%) |
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 1,142,511 | $38.0M | 1.62% |
| TCG Crossover Management, LLC | 697,003 | $23.2M | 2.65% |
| Baker Bros. Advisors LP | 189,866 | $6.31M | 0.06% |
| Trexquant Investment LP | 98,401 | $3.27M | 0.04% |
| Brevan Howard Capital Management LP | 29,177 | $970.4K | 0.01% |
| Savvy Advisors, Inc. | 21,781 | $724.4K | 0.05% |
| Fox Run Management, L.L.C. | 17,707 | $588.9K | 0.10% |
| Hennion & Walsh Asset Management, Inc. | 15,005 | $499.1K | 0.02% |
| Polar Asset Management Partners Inc. | 14,700 | $488.9K | 0.01% |
| Two Sigma Securities, LLC | 8,646 | $287.6K | 0.04% |
| Ieq Capital, LLC | 8,086 | $268.9K | 0.00% |
| Jain Global LLC | 7,749 | $257.7K | 0.00% |
| Cerity Partners LLC | 6,789 | $225.8K | 0.00% |
| Skopos Labs, Inc. | 1,130 | $37.6K | 0.00% |
| Raymond James Financial Inc | 442 | $14.7K | 0.00% |
| Versant Capital Management, Inc | 316 | $10.5K | 0.00% |
| Clearstead Advisors, LLC | 291 | $9.68K | 0.00% |
| Essential Partners LLC | 115 | $3.83K | 0.00% |
| IFP Advisors, Inc | 0 | $1.86K | 0.00% |
| Fortitude Family Office, LLC | 5 | $166 | 0.00% |
| Rialto Wealth Management, LLC | 2 | $67 | 0.00% |
| Jones Financial Companies LLLP | 1 | $33 | 0.00% |
Sold out (25)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Polar Capital Holdings Plc | 1,002,036 | $29.4M |
| Cutter Capital Management, LP | 235,350 | $6.90M |
| Walleye Capital LLC | 150,511 | $4.41M |
| Gsa Capital Partners LLP | 41,029 | $1.20M |
| Squarepoint Ops LLC | 37,920 | $1.11M |
| Capula Management Ltd | 29,749 | $871.6K |
| Verition Fund Management LLC | 27,753 | $813.2K |
| Corebridge Financial, Inc. | 27,688 | $811.3K |
| Allen Investment Management LLC | 21,781 | $638.2K |
| XTX Topco Ltd | 13,801 | $404.4K |
| Group One Trading, L.P. | 13,188 | $386.4K |
| Man Group plc | 11,622 | $340.5K |
| Catalyst Funds Management Pty Ltd | 11,200 | $328.2K |
| SummitTX Capital, L.P. | 10,768 | $315.5K |
| ExodusPoint Capital Management, LP | 10,553 | $309.0K |
| E Fund Management Co., Ltd. | 8,750 | $256.4K |
| Acadian Asset Management LLC | 4,544 | $133.0K |
| Coldstream Capital Management Inc | 1,365 | $40.0K |
| State of Wyoming | 1,314 | $38.5K |
| Mather Group, LLC. | 80 | $2.34K |
| Quadrant Capital Group LLC | 73 | $2.14K |
| Principal Securities, Inc. | 25 | $822 |
| Stephens Consulting, LLC | 15 | $440 |
| South State Corp. | 4 | $117 |
| Global Financial Private Client, LLC | 3 | $88 |
Not filed for Q2 2025 yet (2)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Kodai Capital Management LP | 50,692 | $1.49M |
| Lindbrook Capital, LLC | 257 | $7.53K |